Predictability of future attacks by migraineurs: A prospective observational study

Headache

Volumn 50, Issue 8, 2010, Pages 1296-1305

  Hu, X Henry ^a   Golden, Wendy ^a   Bolge, Susan C ^b   Katic, Bozena ^a   Chen, Ya Ting ^a   Wagner, Samuel ^b   Cady, Roger ^c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Consumer Health Sciences International ^*  (United States)

^c HEADACHE CARE CENTER   (United States)

Author keywords

headache; migraine; National Health and Wellness Survey

Indexed keywords

NON PRESCRIPTION DRUG;

ADULT; ANXIETY; ARTICLE; DAILY LIFE ACTIVITY; DISABILITY; FEAR; FEMALE; FOLLOW UP; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; MENSTRUAL MIGRAINE; METHODOLOGY; MIGRAINE; MIGRAINE DISABILITY ASSESSMENT; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROLOGIC EXAMINATION; OBSERVATIONAL STUDY; PAIN ASSESSMENT; PATIENT EDUCATION; PHYSICIAN; PREDICTOR VARIABLE; PREMENOPAUSE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SELF REPORT; WELLBEING;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANXIETY; ATTITUDE TO HEALTH; COMORBIDITY; FEMALE; FORECASTING; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 77956333685     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01630.x     Document Type: Article

References (21)

1. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache. 2001 41 : 646 657.
2. Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med. 2005 118 (Suppl. 1 3S 10S.
3. Loder EW. Menstrual migraine: Pathology, diagnosis, and impact. Headache. 2006 46 (Suppl. 2 S55 S60.
4. Bigal ME, Lipton RB. The epidemiology, burden, and comorbidities of migraine. Neurol Clin. 2009 27 : 321 334.
5. Hazard E, Muakata J, Bigal ME, Rupnow MFT, Lipton RB. The burden of migraine in the United States: Current and emerging perspectives on disease management and economic analysis. Value Health. 2009 12 : 55 64.
6. Hawkins K, Wang S, Rupnow MFT. Indirect cost burden of migraine in the United States. J Occup Environ Med. 2007 49 : 368 374.
7. Gagne JJ, Bolge SC, Mills DL, Rupnow MF. Comorbidities, economic and humanistic factors associated with migraine: A propensity score analysis of national survey data [Abstract]. Value Health. 2007 10 : A95.
8. Brandes JL. The migraine cycle: Patient burden of migraine during and between migraine attacks. Headache. 2008 48 : 430 441.
9. MacGregor EA, Brandes J, Eikermann A, Giammarco R. Impact of migraine on patients and their families: The Migraine and Zolmitriptan Evaluation (MAZE) survey - Phase III. Cur Med Res Opin. 2004 20 : 1143 1150.
10. Tepper SJ, Spears RC. Acute treatment of migraine. Neurol Clin. 2009 27 : 417 427.
11. Gendolla A. Early treatment in migraine: How strong is the current evidence? Cephalalgia. 2008 28 (Suppl. 2 28 35.
12. Hu XH, Ng-Mak D, Cady R. Does early migraine treatment shorten time to headache peak and reduce its severity? Headache. 2008 48 : 914 920.
13. Goadsby PJ. The "Act when Mild" (AwM) study: A step forward in our understanding of early treatment in acute migraine. Cephalagia. 2008 28 (Suppl. 2 36 41.
14. Hu XH, Raskin NH, Cowan R, Markson LE, Berger ML. Treatment of migraine with rizatriptan: When to take the medication. Headache. 2002 42 : 16 20.
15. Cady RK, Martin VT, Géraud G, et al. Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response. Headache. 2009 49 : 687 696.
16. Scholpp J, Schellenberg R, Moeckesch B, Banik N. Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan. Cephalalgia. 2004 24 : 925 933.
17. Ng-Mak DS, Cady R, Chen YT, Ma L, Bell CF, Hu XH. Can migraineurs accurately identify their headaches as migraine at attack onset? Headache. 2007 47 : 645 653.
18. Foley KA, Cady R, Martin V, et al. Treating early versus treating mild: Timing of migraine prescription medications among patients with diagnosed migraine. Headache. 2005 45 : 538 545.
19. Stewart WF, Lipton RB, Whyte J, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology. 1999 53 : 988 994.
20. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalagia. 1999 19 : 107 114.
21. U.S. Census Bureau. Table 1128: Adult computer and adult internet users, by selected characteristics 1995 to 2006. In: Statistical abstracts of the United States: 2008. 127th ed. Washington, DC : Government Printing Office, 2008 : 719.